Search research articles
Contact Us
Filters
Showing results (11-20 of 37) with videos related to
Page
of 4
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 1, 2025
Cytomegalovirus-specific cell-mediated immunity for prediction of post-prophylaxis CMV disease in a phase 3 trial of letermovir vs valganciclovir prophylaxis in donor CMV-seropositive recipient CMV-seronegative kidney transplant recipients
Ajit P Limaye, Marta Crespo, Nassim Kamar, et al.
The Lancet. Haematology
|
December 24, 2023
Efficacy and safety of extended duration letermovir prophylaxis in recipients of haematopoietic stem-cell transplantation at risk of cytomegalovirus infection: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Domenico Russo, Michael Schmitt, Sylvain Pilorge, et al.
Antiviral Therapy
|
July 25, 2018
Interim analysis of a 3-year follow-up study of NS5A and NS3 resistance-associated substitutions after treatment with grazoprevir-containing regimens in participants with chronic HCV infection
Frederick Lahser, Angela Galloway, Peggy Hwang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 1, 2025
An Analysis of Cytomegalovirus-Specific Cell-Mediated Immunity in a Phase 3, Randomized, Placebo-Controlled Trial of Letermovir Prophylaxis in Cytomegalovirus-Seropositive Recipients of an Allogeneic Hematopoietic Cell Transplant
Genovefa A Papanicolaou, Sanjeet S Dadwal, Ella J Ariza-Heredia, et al.
The Journal of Pediatrics
|
May 2, 2006
A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000
Benjamin L Shneider, Morton B Brown, Barbara Haber, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
April 26, 2016
Long-Term Follow-Up of Children Treated With Peginterferon and Ribavirin for Hepatitis C Virus Infection
Barbara Haber, Estella Alonso, Alejandra Pedreira, et al.
Hepatology (Baltimore, Md.)
|
May 25, 2013
Evaluating progression of liver disease from repeat liver biopsies in children with chronic hepatitis C: a retrospective study
Parvathi Mohan, Bruce A Barton, Michael R Narkewicz, et al.
The Pediatric Infectious Disease Journal
|
January 19, 2024
Pharmacokinetics, Safety, and Efficacy of Letermovir for Cytomegalovirus Prophylaxis in Adolescent Hematopoietic Cell Transplantation Recipients
Andreas H Groll, Johannes H Schulte, Ali Bülent Antmen, et al.
Clinical and Molecular Hepatology
|
May 29, 2019
An integrated analysis of elbasvir/grazoprevir in Korean patients with hepatitis C virus genotype 1b infection
Youn Jae Lee, Jeong Heo, Do Young Kim, et al.
The Journal of Pediatrics
|
June 11, 2013
Health related quality of life in patients with biliary atresia surviving with their native liver
Shikha S Sundaram, Estella M Alonso, Barbara Haber, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 37) with videos related to
Sort By:
Page
of 4
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 1, 2025
Cytomegalovirus-specific cell-mediated immunity for prediction of post-prophylaxis CMV disease in a phase 3 trial of letermovir vs valganciclovir prophylaxis in donor CMV-seropositive recipient CMV-seronegative kidney transplant recipients
Ajit P Limaye, Marta Crespo, Nassim Kamar, et al.
The Lancet. Haematology
|
December 24, 2023
Efficacy and safety of extended duration letermovir prophylaxis in recipients of haematopoietic stem-cell transplantation at risk of cytomegalovirus infection: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Domenico Russo, Michael Schmitt, Sylvain Pilorge, et al.
Antiviral Therapy
|
July 25, 2018
Interim analysis of a 3-year follow-up study of NS5A and NS3 resistance-associated substitutions after treatment with grazoprevir-containing regimens in participants with chronic HCV infection
Frederick Lahser, Angela Galloway, Peggy Hwang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 1, 2025
An Analysis of Cytomegalovirus-Specific Cell-Mediated Immunity in a Phase 3, Randomized, Placebo-Controlled Trial of Letermovir Prophylaxis in Cytomegalovirus-Seropositive Recipients of an Allogeneic Hematopoietic Cell Transplant
Genovefa A Papanicolaou, Sanjeet S Dadwal, Ella J Ariza-Heredia, et al.
The Journal of Pediatrics
|
May 2, 2006
A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000
Benjamin L Shneider, Morton B Brown, Barbara Haber, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
April 26, 2016
Long-Term Follow-Up of Children Treated With Peginterferon and Ribavirin for Hepatitis C Virus Infection
Barbara Haber, Estella Alonso, Alejandra Pedreira, et al.
Hepatology (Baltimore, Md.)
|
May 25, 2013
Evaluating progression of liver disease from repeat liver biopsies in children with chronic hepatitis C: a retrospective study
Parvathi Mohan, Bruce A Barton, Michael R Narkewicz, et al.
The Pediatric Infectious Disease Journal
|
January 19, 2024
Pharmacokinetics, Safety, and Efficacy of Letermovir for Cytomegalovirus Prophylaxis in Adolescent Hematopoietic Cell Transplantation Recipients
Andreas H Groll, Johannes H Schulte, Ali Bülent Antmen, et al.
Clinical and Molecular Hepatology
|
May 29, 2019
An integrated analysis of elbasvir/grazoprevir in Korean patients with hepatitis C virus genotype 1b infection
Youn Jae Lee, Jeong Heo, Do Young Kim, et al.
The Journal of Pediatrics
|
June 11, 2013
Health related quality of life in patients with biliary atresia surviving with their native liver
Shikha S Sundaram, Estella M Alonso, Barbara Haber, et al.
Page
of 4